XWELL (XWEL) Projected to Post Earnings on Tuesday

XWELL (NASDAQ:XWELGet Free Report) is projected to release its Q4 2025 resultson Tuesday, April 21st. Analysts expect XWELL to post earnings of ($1.00) per share and revenue of $2.3710 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Wednesday, April 1, 2026 at 7:00 AM ET.

XWELL (NASDAQ:XWELGet Free Report) last posted its earnings results on Wednesday, April 1st. The company reported ($3.29) EPS for the quarter. The business had revenue of $7.15 million during the quarter. XWELL had a negative return on equity of 352.37% and a negative net margin of 58.17%.

XWELL Trading Up 12.5%

XWELL stock opened at $1.17 on Friday. The firm has a market cap of $9.27 million, a price-to-earnings ratio of -0.23 and a beta of 0.96. The stock has a fifty day simple moving average of $1.08 and a two-hundred day simple moving average of $0.84. XWELL has a 12 month low of $0.26 and a 12 month high of $2.20.

Analysts Set New Price Targets

A number of research firms have commented on XWEL. Wall Street Zen raised XWELL to a “sell” rating in a report on Saturday, April 11th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of XWELL in a report on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, XWELL has an average rating of “Sell”.

Read Our Latest Analysis on XWEL

XWELL Company Profile

(Get Free Report)

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.

Further Reading

Earnings History for XWELL (NASDAQ:XWEL)

Receive News & Ratings for XWELL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XWELL and related companies with MarketBeat.com's FREE daily email newsletter.